Abstract | OBJECTIVE: To compare the prognostic significance of reperfusion assessment by Thrombolysis in Myocardial Infarction (TIMI) flow grade in the infarct related artery and ST-segment resolution analysis, by correlating with clinical outcomes in patients with acute myocardial infarction (AMI). BACKGROUND: Angiographic assessment, based on epicardial coronary anatomy, has been considered the "gold standard" for reperfusion. The electrocardiogram (ECG) monitoring provides a noninvasive, real-time physiologic marker of cellular reperfusion and may better predict clinical outcomes. METHODS: Two hundred fifty-eight AMI patients from the Thrombolytics and Myocardia Infarction phase 7 and Global Utilization of Streptokinase tPA for Occluded coronary arteries phase 1 trials were stratified based on blinded, simultaneous reperfusion assessment on the acute angiogram (divided into TIMI grades 0 & 1, TIMI grade 2 and TIMI grade 3) and ST-segment resolution analysis (divided into: <50% ST-segment elevation resolution or reelevation and > or =50% ST-segment elevation resolution). In-hospital mortality, congestive heart failure (CHF) and combined mortality or CHF were compared to determine the prognostic significance of reperfusion assessment by each modality using chi-square and Fisher's Exact tests for univariable correlation and logistic regression analysis for univariable and multivariable prediction models. RESULTS: By logistic regression analysis, ST-segment resolution patterns were an independent predictor of the combined outcome of mortality or CHF (p = 0.024), whereas TIMI flow grade was not (p = 0.693). Among the patients determined to have failed reperfusion by TIMI flow grade assessment (TIMI flow grade 0 & 1), the ST-segment resolution of > or =50% identified a subgroup with relatively benign outcomes with the incidence of the combined end point of mortality or CHF 17.2% versus 37.2% in those without ST-segment resolution (p = 0.06). CONCLUSION: Continuous 12-lead ECG monitoring can be an inexpensive and reliable modality for monitoring nutritive reperfusion status and to obtain prognostic information in patients with AMI.
|
Authors | A Shah, G S Wagner, C B Granger, C M O'Connor, C L Green, K M Trollinger, R M Califf, M W Krucoff |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 35
Issue 3
Pg. 666-72
(Mar 01 2000)
ISSN: 0735-1097 [Print] United States |
PMID | 10716469
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Streptokinase
- Plasminogen Activators
|
Topics |
- Adult
- Aged
- Blood Flow Velocity
- Coronary Angiography
- Coronary Vessels
(physiopathology)
- Electrocardiography, Ambulatory
- Humans
- Middle Aged
- Myocardial Infarction
(mortality, physiopathology, therapy)
- Plasminogen Activators
(therapeutic use)
- Prognosis
- Reproducibility of Results
- Streptokinase
(therapeutic use)
- Survival Rate
- Thrombolytic Therapy
|